RGVax is the first vaccine to prevent infection of all HPV types linked to cervical and skin cancers. This is achieved by presenting a shared HPV protein on a non-infectious, single-particle vaccine, reducing production costs while leveraging an FDA-approved platform.

Website :

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now closed for Finnish, Italian, South Korean, Taiwanese, and U.S. companies. The call will open soon for South African companies.

Country Programs



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links